Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:861375rdf:typepubmed:Citationlld:pubmed
pubmed-article:861375lifeskim:mentionsumls-concept:C0019829lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C0441771lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C0008902lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C0220784lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:861375lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:861375pubmed:issue6lld:pubmed
pubmed-article:861375pubmed:dateCreated1977-7-29lld:pubmed
pubmed-article:861375pubmed:abstractTextFifty-two patients with pathologic stage III Hodgkin disease were studied in an effort to determine whether location of involved abdominal nodes influenced survival. Treatment consisted of total nodal radiotherapy with or without subsequent combination chemotherapy. Th initial radiation field was the "extended mantle," which included supradiaphragmatic nodes, the splenic hilar area, and paraaortic nodes to the level of L2-L4. Subsequently, lower paraaortic and iliac regions were treated ("lower inverted Y"). Patients with disease limited to the spleen and/or splenic, celiac, or portal nodes ("anatomic substage" III1) had a more favorable 5-yr survival than did patients with involvement of paraaortic, iliac, or mesenteric nodes ("anatomic substage" III2): 93% versus 57%, respectively (p less than 0.05). The addition of combination chemotherapy to total nodal irradiation was associated with improved survival of patients in stage III2, but not of those in stage III1.lld:pubmed
pubmed-article:861375pubmed:languageenglld:pubmed
pubmed-article:861375pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:861375pubmed:citationSubsetAIMlld:pubmed
pubmed-article:861375pubmed:statusMEDLINElld:pubmed
pubmed-article:861375pubmed:monthJunlld:pubmed
pubmed-article:861375pubmed:issn0006-4971lld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:MillerBBlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:GolombH MHMlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:UltmannJ EJElld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:DesserR KRKlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:VardimanJJlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:LesterE PEPlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:GriemM LMLlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:FergusonD JDJlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:BloughRRlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:MoranE MEMlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:OetzelNNlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:KinzieJ JJJlld:pubmed
pubmed-article:861375pubmed:authorpubmed-author:SweetDDlld:pubmed
pubmed-article:861375pubmed:issnTypePrintlld:pubmed
pubmed-article:861375pubmed:volume49lld:pubmed
pubmed-article:861375pubmed:ownerNLMlld:pubmed
pubmed-article:861375pubmed:authorsCompleteYlld:pubmed
pubmed-article:861375pubmed:pagination883-93lld:pubmed
pubmed-article:861375pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:861375pubmed:meshHeadingpubmed-meshheading:861375-H...lld:pubmed
pubmed-article:861375pubmed:meshHeadingpubmed-meshheading:861375-H...lld:pubmed
pubmed-article:861375pubmed:meshHeadingpubmed-meshheading:861375-L...lld:pubmed
pubmed-article:861375pubmed:meshHeadingpubmed-meshheading:861375-P...lld:pubmed
pubmed-article:861375pubmed:year1977lld:pubmed
pubmed-article:861375pubmed:articleTitlePrognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.lld:pubmed
pubmed-article:861375pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:861375pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:861375pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:861375pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:861375pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:861375lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:861375lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:861375lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:861375lld:pubmed